Adrenoceptors in GtoPdb v.2026.1
Jillian G. Baker(Nottingham University Hospitals NHS Trust), Roger J. Summers(Australian Regenerative Medicine Institute), Douglas C. Eikenburg(University of Houston), Robert M. Graham(University of Glasgow), Poornima Balaji(Victor Chang Cardiac Research Institute), Richard A. Bond(University of Houston), Dianne M. Perez(Cerner (United States)), Sergio Parra(University of Houston), J. Paul Hieble(GlaxoSmithKline (Netherlands)), David B. Bylund, Rebecca Hills(University of Edinburgh), Martin C. Michel, K P Minneman(Emory University)
Cited by 1
Related Papers
Structure of a β1-adrenergic G-protein-coupled receptor
|Nature|2008|1.3k
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
|Nature|2011|623
The selectivity of β‐adrenoceptor agonists at human β<sub>1</sub>‐, β<sub>2</sub>‐ and β<sub>3</sub>‐adrenoceptors
|British Journal of Pharmacology|2010|586
The selectivity of <i>β</i>‐adrenoceptor antagonists at the human <i>β</i>1, <i>β</i>2 and <i>β</i>3 adrenoceptors
|British Journal of Pharmacology|2005|535
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390